Could Respitab® simplify your pMDI development programme?
Respitab® is a patented pMDI platform technology designed to support faster and more efficient inhalation product development with next generation low-GWP propellants. The platform simplifies pMDI formulation and manufacturing while helping companies reduce development complexity, scale up challenges, and formulation risks.
If you are formulating a pMDI and facing manufacturing complexity, Respitab® may offer a more direct path.
Book a Consultation Call
We will contact you within 24 hours.